TIR-C: First-in-class targeted therapy for atopic dermatitis
Reference number | |
Coordinator | TIRMED Pharma AB |
Funding from Vinnova | SEK 0 |
Project duration | August 2025 - September 2025 |
Status | Completed |
Venture | Global cooperation 2025 |
Call | Planning grant for international proposal 2025 |